Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors

Introduction: Malignant brain tumors in infants less than 12 months of age are extremely rare, and they have poor prognosis. We evaluated genetic characteristics and response rates of infants with congenital brain tumors subjected to high-dose chemotherapy and autologous stem cell transplant after g...

Descripción completa

Detalles Bibliográficos
Autores principales: Guidi, Milena, Giunti, Laura, Buccoliero, Anna Maria, Santi, Mariarita, Spacca, Barbara, De Masi, Salvatore, Genitori, Lorenzo, Sardi, Iacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160729/
https://www.ncbi.nlm.nih.gov/pubmed/32328470
http://dx.doi.org/10.3389/fped.2020.00135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160729/
https://www.ncbi.nlm.nih.gov/pubmed/32328470
http://dx.doi.org/10.3389/fped.2020.00135

Ejemplares similares